Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
Catheter Precision, Inc., a Delaware corporation, filed this Current Report on Form 8-K on May 14, 2025. The filing announces the financial results for the quarter ended March 31, 2025. The company's common stock trades on the NYSE American under the symbol VTAK.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not reproduced in the provided text.
Material Changes
The filing does not disclose specific material changes versus the prior comparable period. It serves as a notification that results for the quarter ended March 31, 2025, have been issued.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The document explicitly states that the information furnished in Item 2.02 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other SEC filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release Issued on May 14, 2025) for actual financial figures and operational highlights.
- Verify the specific revenue and net income figures for the quarter ended March 31, 2025, as they are not listed in the cover page text.
- Check for any forward-looking statements or updated guidance within the attached press release.
- Confirm the company's liquidity position and debt levels from the full financial statements referenced in the press release.